BioArctic AB (BRCTF)
31.78
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
BioArctic EPS Diluted (Quarterly) : 0.2615 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2615 |
| December 31, 2025 | -0.0106 |
| September 30, 2025 | -0.103 |
| June 30, 2025 | 0.1128 |
| March 31, 2025 | 1.082 |
| December 31, 2024 | -0.033 |
| September 30, 2024 | -0.0213 |
| June 30, 2024 | -0.0725 |
| March 31, 2024 | -0.0627 |
| December 31, 2023 | -0.0926 |
| September 30, 2023 | 0.1304 |
| June 30, 2023 | -0.11 |
| March 31, 2023 | 0.3168 |
| December 31, 2022 | -0.0613 |
| September 30, 2022 | 0.1462 |
| June 30, 2022 | -0.0529 |
| March 31, 2022 | -0.0538 |
| December 31, 2021 | -0.0243 |
| September 30, 2021 | -0.0493 |
| June 30, 2021 | -0.0461 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.0393 |
| December 31, 2020 | -0.0174 |
| September 30, 2020 | -0.0264 |
| June 30, 2020 | -0.0449 |
| March 31, 2020 | 0.0042 |
| December 31, 2019 | -0.0202 |
| September 30, 2019 | -0.0099 |
| June 30, 2019 | 0.1205 |
| March 31, 2019 | 0.0169 |
| December 31, 2018 | 0.4209 |
| September 30, 2018 | 0.0328 |
| June 30, 2018 | 0.0067 |
| March 31, 2018 | 0.0222 |
| December 31, 2017 | 0.0228 |
| September 30, 2017 | -0.0002 |
| June 30, 2017 | 0.0042 |
| December 31, 2016 | 0.1313 |
| September 30, 2016 | -0.0141 |
| June 30, 2016 | -0.0168 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hansa Biopharma AB | -0.279 |
| Swedish Orphan Biovitrum AB | 0.1673 |
| Diamyd Medical AB | -0.0909 |
| BONESUPPORT HOLDING AB | 0.1309 |
| BioInvent International AB | -0.1982 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.24M |
| Revenue (Quarterly) | 47.87M |
| Total Expenses (Quarterly) | 24.64M |
| Enterprise Value | 2.610B |
| Gross Profit Margin (Quarterly) | 95.53% |
| Profit Margin (Quarterly) | 48.54% |
| Earnings Yield | 0.82% |
| Operating Earnings Yield | 1.64% |
| Normalized Earnings Yield | 0.8203 |